Definitive Contract 75N93020C00054
- Not listed
- The Food and Drug Administration awarded a $3.96M cost-plus-no-fee definitive contract to The Leland Stanford Junior University to conduct research on the pathology and pathogenesis of coronavirus infections in animal models. Originally awarded on September 30, 2020, the contract has been modified to extend performance through March 30, 2026. The work was solicited through the FDA's Broad Agency Announcement for regulatory science and innovation, which sought advanced research and development...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to The Leland Stanford Junior University (Stanford University), a private research institution. The $19,155,153 contract is for a 5-year research program to compare multiple vaccine adjuvants and comprehensively assess the immune responses they induce. The goal is to develop "immune fingerprints" of adjuvants using advanced...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the U.S. Department of Health and Human Services, to The Leland Stanford Junior University (Stanford University) on November 25, 2024. The contract, valued at $2,668.05, is to provide custom viral preparation services in which a plasmid DNA will be produced as a live virus using a specific serotype to support the research aims of the NINDS. The...
- This is a $15,800 firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Leland Stanford Junior University, doing business as Stanford University, a private research university located in Stanford, California. The award is for research data, with a completion date of September 30, 2022. Stanford University, as a non-profit educational institution, has extensive experience providing research, consulting, and other...
- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a $6,331,035.00 definitive cost-no-fee contract to The Leland Stanford Junior University (Stanford University) for "Innovations in Functional B Cell Epitope Discovery". The contract is not set-aside and has a period of performance through September 29, 2029. Stanford University, a leading private research institution, will provide research and development services...
- This is a definitive contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to The Leland Stanford Junior University (Stanford University) for $378,000.00. The contract, which does not have a set-aside designation, is for computational thinking to support clinicians and biomedical scientists, and is funded through the American Recovery and Reinvestment Act (ARRA). Stanford University, a renowned private research institution, has been awarded...
- This is a Definitive Contract awarded by the Food and Drug Administration to The Leland Stanford Junior University (Stanford University) with a ceiling value of $6,296,725.48. The contract is for a BAA (Broad Agency Announcement) scientific study on the sequelae and immunopathology of Ebola virus infections. It does not have a set-aside designation. As part of this effort, Stanford has issued a subcontract to the University of California, Los Angeles (UCLA) to collect and provide blood samples...
- This is a delivery order contract awarded to The Leland Stanford Junior University, commonly known as Stanford University, by the National Cancer Institute, a civilian agency within the Department of Health and Human Services. The contract does not have a set-aside designation. Under this $18,588.80 firm fixed price award, Stanford University will provide research and services related to the university's areas of expertise, which include medicine, engineering, computer science, and other...
- This is a firm fixed-price purchase order awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Leland Stanford Junior University (Stanford University) for $15,120.00. The contract is to provide a dataset to support research conducted by the NHLBI's Division of Intramural Research. The contract has a period of performance through June 20, 2025 and does not have a set-aside designation. Stanford University is a renowned...
- The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $398,250 firm-fixed price contract to The Leland Stanford Junior University, doing business as Stanford University, for research and development services to support a molecular diagnostic device that can continuously measure multiple biomarkers in the interstitial space. The contract has a completion date of August 5, 2022 and was awarded on September 30, 2019. The...
This is a $38,210,700.95 definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The Leland Stanford Junior University (Stanford University) to develop small synthetic chemical molecules as broadly active antivirals for the treatment of viral infections, including COVID-19. The contract is not set aside and runs through May 31, 2030. Stanford has engaged several subcontractors to support the work, including Acme Bioscience for medicinal chemistry services, Curia Global Inc. (AMRI) for pharmaceutical development and manufacturing, and the University of North Carolina at Chapel Hill for in vitro and in vivo antiviral assessments. This contract is part of NIAID's broader efforts to advance the development of medical countermeasures and therapeutics to address infectious disease threats.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
63708637184638S | Inotiv, Inc. | Definitive Contract 75N93020C00054 | $432.7k | 3/26/26 | |
63708637184638S | Inotiv, Inc. | Definitive Contract 75N93020C00054 | $27.2k | 12/15/25 | |
63708637184638S | Inotiv, Inc. | Definitive Contract 75N93020C00054 | $2.5k | 10/28/25 | |
63833186184638S | Aravasc, Inc. | Definitive Contract 75N93020C00054 | $108.8k | 10/28/25 | |
63464514184638S | Acme Bioscience, Inc. | Definitive Contract 75N93020C00054 | $186.4k | 8/24/25 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00015 | Exercise an Option | $2.8m | 9/25/25 | |
| P00014 | Funding Only Action | ($377k) | 9/4/25 | |
| P00013 | Other Administrative Action | $0 | 5/21/25 | |
| P00012 | Change Order | $0 | 4/28/25 | |
| P00011 | Other Administrative Action | $0 | 11/25/24 |